It is now on show at the time for us to that our technology is a necessary component plan is plan is to quality health care quality care to patients in the safest environment.. ‘The signing of Monrovia Memorial strengthens Care View the range in the Southern California market,’said Samuel A. The chief executive officer, ‘We have had very good results from our California customers, Little Company of Mary Hospital ., the number of rooms will be enhanced to our technology in his Torrance location and a number of prestigious Southern California hospitals currently looking to take care View system. In the last few years, our Care Plus+ system has proven very successful based on the positive feedback that we participating hospital participating hospital groups.
The company owns a family of patents for RTP801 gene, its RNA and protein product sequences, specific antibodies and gene inhibition in different pathologies.. Quark pipeline is led by PF-655, currently in two Phase II clinical trials for the treatment of wet age -related macular degeneration and diabetic macular edema . In 2006 the siRNA therapeutic candidate was was provided by Pfizer, the implementation of both studies is licensed in collaboration with Quark.Therapeutic proteins is by freeze-drying and coating they with a thin film of different formulations of glass-like of sugar that act to stabilizing their molecular structures This allows them Pharmaceutical enterprises for long periods. Pharmaceutical companies general guidelines general guidelines , develop their terms is substantially trial and error and have to wait and two years see whether the glasses are suitable. These new methods helping pharmaceutical company , the best place the the wording and facilitating medications stabilizing at room temperature for. Room temperature storage is important when the pharmaceutical in sectors the world where in a controlled stock terms are not available intended to be used..